Profil
Ming-Fu Chiang is currently Director at NeOnc Technologies, Inc. and Director at NeOnc Technologies Holdings, Inc. starting in 2025.
Formerly, Director at NeOnc Technologies Holdings, Inc. in 2025.
Education includes a doctorate from Freie Universität Berlin and an MBA from National Taiwan University.
Postes actifs de Alan Chaing
| Sociétés | Poste | Début |
|---|---|---|
NeOnc Technologies, Inc.
NeOnc Technologies, Inc. Pharmaceuticals: MajorHealth Technology Engage in development and commercialization of central nervous system therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Alan Chaing
| Sociétés | Poste | Fin |
|---|
Formation de Alan Chaing
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NeOnc Technologies, Inc.
NeOnc Technologies, Inc. Pharmaceuticals: MajorHealth Technology Engage in development and commercialization of central nervous system therapeutics | Health Technology |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















